NicoElNino / iStock
Jeffrey Capello, the executive vice president and chief financial officer of Beacon Health Options, has joined US biotech company Biogen in the same position.
Capello led all aspects of Beacon’s finance responsibilities, working with its operations, client, strategy and development, and clinical leadership teams. His previous experience includes founding and running his own company, Monomy Advisors, and serving as chief financial officer of Ortho Clinical Diagnostics, Boston Scientific Corporation, and Perkin Elmer. Earlier in his career he was also a partner in the Boston and Amsterdam offices of PwC.
In his new role, Capello will lead Biogen’s business planning, tax, treasury, internal Audit, accounting, and investor relations functions. Based in Cambridge, Massachusetts, be will report to Michel Vounatsos, CEO of Biogen, will be a member of the executive committee.
Capello commented: "I am very excited to join Biogen, a company which is recognized as a pioneer and a leader in treating neurological diseases. I look forward to working with colleagues around the world in our mission to make a difference in the lives of patients."
CEO Vounatsos added: "We are fortunate to have Jeff join Biogen given the depth and breadth of his experience. He comes to Biogen at an exciting time as we execute our business strategy, pursue business development opportunities and build our pipeline."
Biogen, Beacon Health Options, Appointment, Jeffrey Capello, Michel Vounatsos, US
